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Formative research to design a culturally-
appropriate cancer clinical trial education
program to increase participation of African
American and Latino communities
Jennifer Cunningham-Erves1*, Claudia Barajas2, Tilicia L. Mayo-Gamble3, Caree R. McAfee4, Pamela C. Hull2,4,
Maureen Sanderson5, Juan Canedo6,7, Katina Beard8 and Consuelo H. Wilkins1,9,10
Abstract
Background: Addressing knowledge deficiencies about cancer clinical trials and biospecimen donation can
potentially improve participation among racial and ethnic minorities. This paper describes the formative research
process used to design a culturally-appropriate cancer clinical trials education program for African American and
Latino communities. We characterized community member feedback and its integration into the program.
Methods: We incorporated three engagement approaches into the formative research process to iteratively
develop the program: including community-based organization (CBO) leaders as research team members,
conducting focus groups and cognitive interviews with community members as reviewers/consultants, and
interacting with two community advisory groups. An iterative-deductive approach was used to analyze focus group
data. Qualitative data from advisory groups and community members were compiled and used to finalize the
program.
Results: Focus group themes were: 1) Community Perspectives on Overall Presentation; 2) Community Opinions
and Questions on the Content of the Presentation; 3) Culturally Specific Issues to Participation in Cancer Clinical
Trials; 4) Barriers to Clinical Trial Participation; and 5) Perspectives of Community Health Educators. Feedback was
documented during reviews by scientific experts and community members with suggestions to ensure cultural
appropriateness using peripheral, evidential, linguistic, sociocultural strategies, and constituent-involving. The final
program consisted of two versions (English and Spanish) of a culturally-appropriate slide presentation with speaker
notes and videos representing community member and researcher testimonials.
Conclusions: Incorporating multiple community engagement approaches into formative research processes can
facilitate the inclusion of multiple community perspectives and enhance the cultural-appropriateness of the
programs designed to promote cancer clinical trial participation among African Americans and Latinos.
Keywords: Cancer, Disparities, Clinical trials, African Americans, Latinos, Education, Recruitment, Community health
educators (CHEs)
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Background
Cancer remains a public health threat as the second
leading cause of death nationally and worldwide [1]. Mi-
norities continue to disproportionately share the burden
[2]. African Americans have the highest cancer death
rates and shortest survival rates for most cancers. While
cancer death rates are lower among Latinos compared
to most racial/ethnic groups, cancer is the leading cause
of death for this group [3]. Participation of racial/ethnic
minorities in cancer clinical trials and biospecimen-
based research is necessary to be able to identify and test
prevention, detection, and treatment methods that are
effective for these groups. Yet, research participation of
racial/ethnic minorities is alarmingly low. For example,
about 3 % of all adult cancer patients enroll in clinical
trials [4], and participation is lower among minorities
compared to Whites, with minorities representing only 2
% of cancer clinical trial participants but 40% of the U.S.
population [4, 5]. Consequently, 20% of studies fail to be
completed due to insufficient enrollment [6, 7], imped-
ing advancement of prevention and treatment methods
[8]. For studies that do succeed, yet have low minority
participation, there is uncertainty of whether the medical
interventions can be generalized to different racial/eth-
nic groups to know whether they will work equally well
in these groups [9, 10]. Improving clinical trial participa-
tion and biospecimen donation in racial/ethnic minority
groups would increase diversity in participation and en-
able the development of medical interventions that are
effective across racial/ethnic groups or need to be modi-
fied for specific groups [10].
Barriers to clinical trial participation for African
Americans and Latinos are numerous, complex, and
some even insurmountable [8, 11]. Examples include low
patient trust in physicians and the research process, fear,
and systemic social inequalities [12–15]. Lack of aware-
ness and knowledge about research and opportunities
for participation are among the strongest barriers [14,
16–19]. Clinical trial education for patients and their
families, clinic staff, communities, and institutions have
shown promise to help identify, accrue, and retain all
trial participants [16, 20–27]. However, these interven-
tions yield inconsistent results. For example, a biospeci-
men education intervention using a community based
participatory research approach demonstrated fewer
negative associations with biospecimen participation;
however, participation remained unchanged [26]. More
research is needed to identify the various factors contrib-
uting to patient and community knowledge deficiencies
on clinical trials in order to develop targeted educational
programs that can potentially improve participation
outcomes.
Targeting health communication maximizes the “fit”
of information by customizing an educational program
to a subgroup of people with unique characteristics [28].
Application of targeting in the development of educa-
tional programs has improved many preventive health
behaviors (e.g., cancer screening) [29]. Targeting is de-
scribed as “a single program for a defined population
subgroup that takes into account characteristics shared
by the subgroups‘ members and increases cultural
sensitivity of health programs” [30]. Kreuter et al. [31]
recommend using peripheral, evidential, linguistic, socio-
cultural, and constituent-involving strategies to develop
targeted programs to achieve cultural appropriateness
[31]. Peripheral strategies increase the appeal of commu-
nication through the title, fonts, colors, and/or images.
Evidential strategies provide evidence or data on the im-
pact of a health issue on a certain group. Linguistic
strategies fit the program to the native language of a cer-
tain group, which could involve translations of content.
Sociocultural strategies address health issues from the
social and cultural values of a certain group. Last,
constituent-involving strategies ensure community
members inclusion in program planning, decision-
making, and/or staff [31].
Formative research combines observational data col-
lection and analysis with program development in an it-
erative process, such that the data analysis guides the
program development rather than answering specific a
priori research questions [32, 33]. Formative research is
commonly used to develop intervention programs, and it
can particularly be used to develop targeted programs to
ensure cultural sensitivity [33–35]. It involves the use of
quantitative and/or qualitative methods to understand
knowledge gaps and social norms of a cultural group,
identify behaviors to be addressed, and inform strategies,
messages, and channels of communication [33, 36]. The
goal of formative research is to learn and incorporate
the culture of the target community, build trust, encour-
age academic-community partnerships, and promote
program acceptance [33].
The application of community-engaged research
(CEnR) in the formative research process offers the
potential to optimize the likelihood that the interven-
tion will have its intended effect [26, 27, 37]. Com-
munity engagement is defined as the collaboration of
groups to identify and address issues affecting their
well-being [38]. The level of community involvement
can range along a continuum, ranging from outreach
to shared leadership [38], with the goals of the en-
gagement effort aligning with those of formative re-
search. Little guidance is currently available in the
scientific literature on how to apply CEnR approaches
in a formative research process to improve incorpor-
ation of cultural information into an educational
program, in particular for educational programs aimed
to increase participation of African Americans and
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Latinos in cancer clinical trials and biospecimen do-
nation for research.
Preliminary work
The Meharry-Vanderbilt-TSU Cancer Partnership
(MVTCP) was formed in 1999 between Meharry Med-
ical College (MMC) and Vanderbilt-Ingram Cancer
Center (VICC) and added Tennessee State University
(TSU) to the partnership in 2006. The MVTCP Cancer
Outreach Core fosters community-academic partner-
ships, conducts outreach activities, and facilitates CEnR
related to cancer disparities. In 2009, the core and six
community partners serving local African American, La-
tino, and rural communities conducted six town halls
(N = 96). A town hall is a grop session that is conversa-
tional in nature that gains the community’s input on
health research priorities [39]. The community members
discussed cancer clinical trial participation and strategies
to overcome barriers to participation among racial/eth-
nic minorities and medically underserved communities.
Those engaged were African American (75%), Latino
(14%), rural White (6%), and other/not reported (5%).
Most (65%) had not participated in biomedical research.
Two emerging themes were distrust and uncertainty in
medical research. Suggestions to reduce distrust were to
improve communication between research institutions
and the community, conduct research on health issues
important to the community, and provide clinical trial
education programs in the community.
Using this feedback, the partners sought to increase
community awareness and local support for cancer clin-
ical trials. VICC then collaborated with the Education
Network to Advance Cancer Clinical Trials (ENACCT),
a national organization, to use one of its educational
programs- entitled, “What Are Cancer Clinical Trials
and Why Are They Important for My Community?” [22,
27] Cancer clinical trial topics included types, phases,
risks and benefits, and protections. The partners made
minor modifications to the program to adapt it for the
local communities (i.e., different background and color
scheme, inclusion of local statistics on cancer, added
logos for partners and contact information for local re-
sources, changed some images and wording, and chan-
ged some content for cultural appropriateness).
ENACCT provided a 1.5-day, train-the-trainer program
to community health educators (CHEs) (4 African
American, 2 Latino, 1 White) volunteering from the
partner organizations. From 2010 to 2011, the CHEs im-
plemented 17 60-min, educational sessions with 245 par-
ticipants (130 African American, 46 Latino, and 69
White) (unpublished observations). While the idea for
this program initiated from the community in the town
halls, a major limitation was the lack of African
American and Latino community members’ involvement
in the development of the original ENACCT program.
The partners concluded that further research was
needed to ensure the program: 1) was culturally-
appropriate, and 2) addressed common audience ques-
tions and concerns.
Purpose of formative research
This paper describes the formative research process used
to design a single-session, in-person educational pro-
gram aimed to increase participation in cancer clinical
trials and biospecimen donation. Our primary goal was
to collect data that could be used to develop an effective,
culturally-appropriate program for African American
and Latino communities. To ensure the program was
culturally-appropriate, we used peripheral, evidential,
linguistic, and sociocultural strategies to design the pro-
gram using the feedback. We also used a constituent-
involving strategy (i.e., community engagement) to: (1)
engage community members in all research phases of
program development; and (2) incorporate community
feedback into the program.
Methods
We used the modified ENACCT module described
under Preliminary Work as a starting point to gather
community input. The initial plan was to adapt this
existing program; however, the formative research
process and community engagement led to the gener-
ation of nearly all new content, which resulted in a new
educational program. Our team iteratively designed the
new program through a community-engaged, formative
research process over 3 years. The formative research
process consisted of four phases of data collection and
program development while gaining feedback through
community participation at each phase. Figure 1 depicts
the timeline of the phases to develop the final, new pro-
gram. This research was approved by Vanderbilt Univer-
sity Institutional Review Board.
Phase 1: partnership development, 2014
Two community organizations, Matthew Walker Com-
prehensive Health Center (MWCHC, lead organization
of the Nashville Health Disparities Coalition, primarily
serving African Americans) and Progreso Community
Center (PCC, lead organization of the Nashville Latino
Health Coalition, primarily serving Latinos) entered a
partnership with the Meharry-Vanderbilt Alliance
(MVA) and the MVTCP Cancer Outreach Core to de-
velop the cancer clinical trial educational module based
on direct input from African American and Latino com-
munities. We continued use of a CEnR approach
throughout this research process to: 1) promote a suc-
cessful, collaborative process; and 2) ensure the forma-
tive research goal was met. Partners met during and
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throughout each phase (i.e., monthly on average) to
make changes to the program iteratively and collectively
using community feedback.
Phase 2: community-member focus groups, 2014–2015
Study design and setting
The focus group phase of the formative research process
used an observational qualitative study design. We con-
ducted qualitative focus groups to inform new content
for the educational module, specifically to gather and
analyze data regarding the perception, acceptability, and
concerns with content. As a part of the community-
engaged process, we started with the modified ENACCT
clinical trial education module that the team used previ-
ously and iteratively adapted the content into a new
module based on the focus group data from African
American and Latino community members in Nashville,
Tennessee.
Sampling and recruitment
A purposive sampling method was used to select partici-
pants. Partnership representatives identified community
members or other community-based organizations to re-
cruit participants based on the eligibility criteria below.
Ten focus groups represented African Americans (n = 4),
Latinos (n = 4), cancer survivors (n = 1), and the CHEs
who were previously trained and delivered the modified
ENACCT module (n = 1), as described under Prelimin-
ary Work. The CHEs were included so they could
describe their experience in teaching the material, the
challenges they encountered, and the feedback they re-
ceived from community members to improve content
and program delivery. Recruitment methods were flyers,
word-of-mouth, and community-based organizations
(CBOs).
Eligibility criteria
Inclusion criteria were: 1) female or male; 2) English-
speaking and Spanish/English speaking if Latino; 3)
African American or Latino; and 4) age 18 and older.
The cancer survivor group had additional inclusion cri-
teria of being a cancer survivor. The CHE group had
additional inclusion criteria of having conducted at least
one educational session in the previous phase of the
project.
Procedures
First, a research team member who self-identified as
African American or Latino (congruent to the race/eth-
nicity of focus group members) presented the modified
ENACCT educational module that was used in the pre-
vious phase of the project (see Preliminary Work). Next,
a focus group discussion was moderated by one of the
research team members. Using the literature and our
past research, the moderator’s guide queried barriers to
research and program cultural appropriateness (e.g.,
comprehension, delivery effectiveness, relevance) (See
Supplementary Material for Focus Group Questions).
Fig. 1 Community-engaged cancer clinical trial program adaptation process
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Prior to focus groups, participants provided written con-
sent and completed a brief survey on demographics and
trust in medical researchers. The 90-minute discussions
were audio-recorded and transcribed verbatim. Partici-
pants were compensated a $50 gift card and a meal.
Data analysis and establishing trustworthiness
The qualitative data coding and analysis were managed
by the Vanderbilt University Qualitative Research Core.
An a priori, hierarchical coding system was developed
and refined using the moderator’s guide and a preliminary
review of four transcripts. Major categories included: 1)
opinions of presentation; 2) opinions and questions on in-
formation; 3) presenter experience; 4) Latino/African
American specific issues; and 5) barriers to clinical trial
and biospecimen participation. After major categories
were identified, they were further divided from one to 13
subcategories, with each subcategory having additional
levels of hierarchical divisions. Each category had written
definitions and coding rules.
Experienced qualitative coders first established reliabil-
ity in using the coding system, then independently coded
the transcripts. Line-by-line coding of each transcript
was done and compared, and discrepancies resolved to
create a single coded transcript. Each statement was
treated as a separate quote and could be assigned up to
five different codes. Transcripts were combined and
sorted by code. Using an iterative, inductive-deductive
approach, the coded quotes were interpreted, and
higher-order themes identified. This process was con-
ducted until thematic saturation was reached. Strategies
to ensure rigor included thick, rich descriptions, peer
debriefing, and member checks [40]. Management of
transcripts, quotations, and codes was performed using
Microsoft Excel 2016 and SPSS version 24.0.
Iterative revision process
Starting with the modified ENACCT educational module
that our team used in the previous phase, the members
of the community-academic partnership team used the
focus group findings to iteratively modify the module
content, as well as the program delivery methods, re-
cruitment/retention strategies, data collection, and im-
plementation plan. A subgroup of the research team met
regularly to discuss focus group findings and the Power-
Point presentation, making recommendations for
changes. Then, all members of the partnership met to
discuss the recommended changes and identify add-
itional needed modifications. Following each meeting, a
new iteration of the PowerPoint presentation was pro-
duced using peripheral, evidential, linguistic, and socio-
cultural strategies. A final meeting was held to ensure
the program was culturally appropriate and incorporated
all of the feedback to the best extent possible.
Phase 3: Reading assessment with community input,
2016–2017
Scientific review
We identified two experts in cancer clinical trials from
Vanderbilt-Ingram Cancer Center to review the content
for accuracy. Selection criteria for content reviewers
were: experience in cancer clinical trial research, willing-
ness to review the PowerPoint presentation, and ability
to complete the review in a timely manner. Content was
deemed evidential if experts did not find inaccurate or
obsolete information. Corrections were completed if
identified by experts.
Reading level assessment
Prior to the assessment, members of the community-
academic partnership reviewed the presentation and ap-
plied a linguistic strategy to replace technical terms with
“lay” language and simplify the text to under a 6th grade
reading level. Definitions were added to the slide or
presenter notes. Reading level assessments were con-
ducted using the Flesch Reading Ease and Flesch-
Kincaid Grade Level assessments on the presentation.
The Flesch Reading Ease assessment provides a score to
determine level of difficulty of reading material. Material
that is easier to read has higher scores, while those with
lower scores are more difficult to read. The Flesch-
Kincaid Grade Level assessment indicates the reading
level using the U.S. grade level [41]. At this time, we
were unable to identify tools to assess the reading level
of the Spanish version.
Cognitive interviews with community members
To further evaluate the material’s comprehensiveness
and ease of comprehension, we conducted 60-min inter-
views with two community members (one African
American and one Latino) with a high school level edu-
cation (i.e., a linguistic strategy). Cognitive interviews are
commonly used in the development educational pro-
grams, during which community members state how
they perceive and interpret materials and potential prob-
lems [42]. Specifically, we used a “think aloud” [43] ap-
proach for participants to convey their thoughts on each
slide, identifying text that was difficult to understand or
unclear. Slight modifications were made to problematic
text.
Phase 4: community review of new educational module,
2017
We presented the new educational presentation to two
community groups to pretest the intervention’s accept-
ability. An African American research team member
presented to the MVTCP Community Advisory Board
(CAB), including primarily African American cancer sur-
vivors, community members, and representatives of
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cancer-focused organizations. A Latina research team
member presented to a group of Latino community
members within our cancer outreach network who have
demonstrated interest in research studies. At the end of
the presentation, participants shared their opinions
aloud and completed a brief survey. Collectively, these
evaluative methods gained participants’ feedback on cul-
tural appropriateness, applying all of the cultural-
targeting strategies. The research team discussed the
feedback and revised the presentation accordingly.
Results
A summary of results at each phase of program develop-
ment is provided below. Using the cultural-targeting
strategies recommended by Kreuter et al. (2003) [31],
suggestions and revisions at each phase are organized
under the following four categories: 1) peripheral; (2)
evidential; (3) linguistic; and (4) sociocultural strategies.
The constituent-involving strategy was incorporated
with community leader and member involvement at
each stage of the development process, through the
community engagement process. Table 1 organizes each
phase of program development by the cultural-targeting
strategies (first column) and aligns the explicit sugges-
tions for changes by participants (second column) with
the specific cultural adaptations that were made to each
suggestion (third column), and the relevant barriers to
clinical trial participation that the changes address
(fourth column).
Community-member focus groups
Majority of focus group participants were female
(78.8%), Latino (60.0%), and had an annual income of
less than $25,000 (53%). Nearly one-third were married
(32.9%), had a bachelor’s degree (29.4%), and were
employed full-time (27.1%) (See Table 2). Five main
themes emerged from these focus groups: 1) Community
Perspectives on Overall Presentation; 2) Community
Opinions and Questions on the Content of the Presenta-
tion; 3) Culturally Specific Issues to Participation in
Cancer Clinical Trials; 4) Barriers to Clinical Trial
Participation; and 5) Perspectives of Community Health
Educators. Table 3 lists the definition of each theme, the
sub-themes, example quotes from participants.
Community perspectives on the overall presentation
Overall, participants perceived the presentation was
clear, images appropriate, and language simple. How-
ever, participants suggested changing the order of some
slides for smoother transitions throughout the presenta-
tion. Additional suggestions were to enhance blurred im-
ages, present cancer statistical information by race/
ethnicity and gender, add a testimonial on experience
with clinical trial participation, and end with a takeaway
message. The target audience of African Americans and
Latinos aged 18 and up was deemed appropriate, yet
they also encouraged all ages to view the presentation.
The small audience size (12–15 people) for the presenta-
tion was acceptable, creating discussion and keeping
focus. For location, they said it was important to have an
enclosed space to limit distractions for participants and
the presenter. Lastly, participants stated they needed
presentation handouts and an information sheet on how
to enroll in clinical trials.
Community opinions and questions on the content of the
presentation
Participants believed the presentation increased aware-
ness and was appropriate and respectful. Yet, they per-
ceived the information too specific at times and wanted
more general information. They more general informa-
tion (e.g., statistics), and pictures that were diverse and
not reflecting one racial/ethnic group. Participants also
believed the clarity of the presentation could be im-
proved by adding information on cancer biology and risk
factors, and more details on the clinical trial and biospe-
cimen collection process. Furthermore, it was suggested
to target content to Latino and African American audi-
ences separately while adding personal testimonials on
participant clinical trial experiences. Specifically, images
and testimonials should match race or ethnicity of target
audience.
Culturally specific issues to participation in Cancer clinical
trials
Both groups emphasized the history of abuse in medical
research and being “lied to” by medical researchers and/
or physicians. Many participants conveyed high levels of
distrust in providers/researchers. The cancer disparity
among African Americans was discussed and culture
(e.g., disbelief in the cancer disparity) contributed to low
cancer clinical trial participation rates among partici-
pants. For Latinos, being Spanish-speaking was a specific
issue, creating fear by not understanding the material
presented for cancer clinical trial participation.
Barriers to clinical trial participation
Top barriers were lack of information on the research
process, followed by fear of research methods, and dis-
trust in doctors/researchers. Additional barriers cited by
participants included concerns regarding privacy and
costs in research participation. A specific barrier to the
Latino community was immigration status. Being “un-
documented” limited their access to clinical trials and
healthcare. A specific barrier to the African American
community was limited access to clinical trials and
healthcare.
Cunningham-Erves et al. BMC Public Health          (2020) 20:840 Page 6 of 14
Table 1 Summary of Suggestions, Changes, and Barriers to Research Culturally-Targeted at Each Phase of the Adaptation Process




Suggestions Changes Targeted Barriers
Peripheral Increase font size on images providing
cancer statistics. (AA)
Removed those images and added images with larger
font and fewer statistics
-None
Pictures need to show clinical trials are for
everyone not a specific race/ethnicity (AA)
Pictures were changed to reflect all races and
ethnicities
-In ability to understand
information on research
-Lack of information on the
research process
Change slide background color (AA) Changed slide background color from light green to
white
-None
Increase clarity in presentation (AA, L) Layout of slides modified to improve flow of
presentation; Removed content outlining purpose of
presentation; Added two takeaways to presentation
-Inability to understand
information on research
Evidential Cancer statistics should be presented by
race/ethnicity and gender (AA)
Changed to overall cancer statistics for all and top
cancers by race/ethnicity and gender




Add a video on community member
experience in cancer clinical trial
participation (L)
Developed videos of community members (1AA, 1 L)
telling their experience in participating in a cancer
clinical trial.
-Lack of information on the
research process
-Fear of research methods
Need researcher perspective on research
process (AA)
Developed videos of researchers (1 AA, 1 L) telling the
importance of research.
-Lack of information on the
research process
Linguistic Increase clarity of who could participate in
clinical trials (CHE)
Added statement that EVERYONE could participate
with examples
-Lack of information on the
research process






Offer presentation in Spanish (L) Translated the English version into a Spanish version -Inability to understand
information on research
Sociocultural Provide handouts on presentation and
information on ways to identify clinical trials
(L)
Added handouts during presentation and added
information to resource slide on where to find clinical
trials
-Lack of information on the
research process
-Limited access to clinical
trials and healthcare
Add information culturally appealing to the
community (AA, L)
-Add content on cancer (e.g., definition, etiology, risk
factors), clinical trials (e.g., phases of trials and process
at each phase, benefits, costs, sources to get
information or register for clinical trials), and
protections (e.g., Belmont Principles)
-Lack of information on the
research process




Suggestions Changes Targeted Barriers
Peripheral No Suggestions None -None
Evidential Possible barriers to add include injury, travel
and lodging costs, and costs to those
uninsured
Added these barriers to slides along with information
on patient assistance programs




Update presenters’ notes with information
on genetic testing in biospecimens
Updated presenters’ notes with information provided
on genetic testing in biospecimens
-Lack of information on the
research process
-Fear of research methods
Linguistic Increase clarity on cancer treatment Added “Cancer is more than one disease” to clarify
that more than one treatment is needed to prevent
cancer
-Lack of information on
cancer
Remove “safely” from “How to safely
participate in clinical trials to improve cancer
treatment options for your community.”
Removed the slide -None
Sociocultural No Suggestions None -None
Phase III: Reading Level Assessment
Cunningham-Erves et al. BMC Public Health          (2020) 20:840 Page 7 of 14
Perspectives of community health educators
Overall, educators felt confident and comfortable in
presenting the material after training. They under-
stood their role and how important it was for them
to teach the community about cancer, clinical trials,
and biospecimen research. They appreciated the
opportunity to assist in adapting the presentation and
providing input on content and aesthetics based on
their prior experiences. Lastly, their recommendation
was to recruit community leaders with rapport in
communities to serve as future educators, making the
program more targeted.





Suggestions Changes Targeted Barriers
Peripheral/
Linguistic
Add visuals to compliment topic Identified topic-appropriate visuals -Lack of information on the
research process
-Fear of research methods
Evidential Clarify difference between patient care
versus research costs
Added examples of patient care and research costs -Lack of information on the
research process
Update presenters notes to include
additional information on clinical trial
process
Added information on what happens at each phase of
clinical trials to presenter notes
-Distrust in doctors/
researchers
-Lack of information on the
research process
-Fear of research methods
Linguistic Use simpler term for clinical trial phases Changed to “how a clinical trial gets to you” -Lack of information on the
research process -Fear of
research methods




Suggestions Changes Targeted Barriers
Peripheral Aesthetics of video testimony could be
improved (AA)
Decided not to refilm the video because the
suggestion did not apply to the content
-Distrust in doctors/
researchers
-Lack of information on the
research process
-Fear of research methods
Evidential Consider listing risks of being in a clinical
trial (AA)
Decided not to list risk because they can vary by
clinical trial; added examples of risks for a specific
clinical trial to presenter notes to use if asked
-Lack of information on the
research process
-Fear of research methods
Linguistic Words could be more “community friendly”
(AA, L)
Minor modifications to increase clarity -Inability to understand
information on research
Sociocultural How to participate in clinical trials if
uninsured, undocumented, and speaks no
English. (L)
Added to presenter notes: being undocumented as a
barrier; translators in place in most instances for
Spanish-speaking individuals; and patient assistance









Suggestions Changes Targeted Barriers
Peripheral Change pictures to be more appealing (L) Replaced pictures -None
Evidential Additional clarity needed on informed
consent process (AA)
Added information to presenters’ slides on informed
consent process





Linguistic No Comments None -None
Sociocultural Use presenters from disadvantaged
background (AA)




The following abbreviations represent who made the suggestions: (AA), African American community member; (L), Latino community member; (CHE), Community
Health Educator
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Cultural adaptations using focus group findings
Based on the focus group findings, suggestions for
changes and barriers to clinical trial participation, we ap-
plied the four cultural-targeting strategies to perform
the adaptations listed in Table 1. From the peripheral
perspective, the slide background color was changed
from light green to white to increase the aesthetic appeal
of the presentation. Pictures were changed to reflect all
races and ethnicities, indicating clinical trials were for
everyone not a specific race or ethnicity. The layout of
the slides were altered to be more visually appealing,
and the slide order was modified to improve the flow of
the presentation. The targeted, evidential statements re-
garding cancer epidemiology (i.e., incidence, mortality,
and survival rates) among both racial/ethnic groups were
altered to reflect general cancer incidence and mortality
rates and a list of top 3 cancers by race/ethnicity and
gender. Furthermore, video testimonials were added
to the presentation. In applying the linguistic strategy,
we hired a translator to translate the English version of
the presentation to a second Spanish version. For video
testimonials, the Latino community member and the re-
searcher each made two videos on the importance of re-
search (2 English and 2 Spanish versions) plus two
videos with and an African American community mem-
ber and researcher (English version only). Images and
graphics that were not understood by community mem-
bers were removed. Last, from the sociocultural perspec-
tive, we ensured the program fit the specific needs of the
participants of each cultural group by adding content on
facts related to cancer (e.g., definition, etiology, and risk
factors), clinical trials (e.g., phases of clinical trials and
process at each phase, benefits, costs, sources to get in-
formation or register for clinical trials), and protections
(e.g., Belmont Principles). We removed the content out-
lining the purpose of the presentation and added two
takeaways from the presentation.
Program finalization
Scientific review
Clinical trial experts perceived the presentation as
“great”, particularly the content, format, and diversity in
images. Minor modifications were made to increase clar-
ity from the linguistic and evidential perspectives. For






Black or African American 31 36.5
Hispanic/Latino 51 60.0
Other/More than one race 3 3.5
Ethnicity
Hispanic/Latino 51 60.0
Not Hispanic or Latino 22 25.9




Living with a partner 10 11.8
Married 28 32.9
Separated 8 9.4
Single (never married) 23 27.1
Widowed 2 2.4
Education
No High School Diploma 12 14.1
GED or High School Diploma 20 23.5
Some College 15 17.6
Associates Degree 4 4.7
Bachelors Degree 25 29.4
Doctoral Degree 1 1.2
Missing 1 1.2
Employment Status
Employed Full Time (32h hours per week) 23 27.1
Employed Part Time (less than 32 h per week) 18 21.2
Disability 3 3.0
Retired 4 3.5












Table 2 Participant Demographics (n = 85) (Continued)
Variable Number Percent
$100,000–$149,999 4 4.7
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Table 3 Emerging illustrating themes on participants views towards cancer clinical trials and the education program
Theme Subthemes Examples of Participant Statements
Community Perspectives on the Overall Presentation
Definition: Describes the participants’ thoughts on the












“... the information is very clear. It does not contain any
scientific or elevated information that is difficult to understand.
I think that most of the population can understand it.”
(Clarity, Latino)
“Bigger, 50 to 100 people, they begin to look at the ceiling. In
that way, you have the control of the group. Bigger groups,
you lose control of the group.” (Size of Audience, Latino)
“... the language was okay. I thought it was simple enough. I
can’t imagine how more simpler you could explain that. I
would be infuriated if you tried to break it down anymore, but
that’s a personal thing...” (Clarity, African American)
“… the color, I don’t think that works for a lot of people ... you
can dismiss it. (Other, African American)
Community Opinions and Questions on the Content of the
Presentation
Definition: Describes the participants’ thoughts and questions



























”Do we have bad habits that we are not aware of and that is
contributing to so much cancer, for example, no??” (Not
Enough Information, Latino)
“...a definition of what a clinical trial is.” (Not Enough
Information, Latino)
“Put positive stuff behind it just to show numbers and stuff.
You know, like you got like 45% of people having success in
going through clinical trials or something like that.” (Not
Enough Information, African American)
“Maybe if you could ... if somebody would come forward and
do a testimony ... if they’ve been in that type of situation or
something going on with them with cancer or something,
maybe they would come and tell they story, if somebody
would come forward.” (Not Enough Information, African
American)
Culturally Specific Issues to Participation in Cancer Clinical Trials







“Clearly, there’s an understanding that there’s a huge mistrust,
particularly in the African American community, and so when
you see information about HIPAA regulations or that kind of
thing, that is a glimmer of hope for many people.” (Mistrust
in Research, African American)
“Your lifestyle and your diet, that’s why ... (inaudible) ... and the
very unhealthy way they eat. They are brought up with that.
What they idolize is not healthy. I mean, how often do you
hear ... (inaudible) ... eating healthy, wheat bread? I eat Kool-
Aid, hot chips, corn flakes …” (Diet, African American)
“I also think it’s because of fear and because many people
don’t know how to read. They don’t have this ability that we
have.” (Fear of Research Methods, Latino)
“I think it’s also trying to get us (the Spanish community) to
participate more, because there is little information out there
for us to go …” (Language Barrier, Latino)
Barriers to Clinical Trial Participation













“Talk more about the fear we have to participate, because I
hesitate because I think, well, what are the risks or side
effects?” That is the biggest fear. People don’t want to feel like
a guinea pig.” (Fear of Research Methods, Latino)
“I think lack of information is the major problem. There are a
lot of people that are afraid of what is going to happen to
them, side effects, because a lot of people don’t like to take
medicine, including me. Also, about insurance and all that,
that also should be clear ....” (Lack of Information, Latino)
“I got a problem with these clinical trials. They say they tell
you about the risks and all this and all that, but they ain’t ...
like she said, she’s got asthma, but then they gave her an
inhaler that had something, you know, that she was allergic to
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example, we added additional costs (i.e., travel and lodg-
ing, injury, out-of-pocket expenses) to clinical trial par-
ticipation among these groups). We added or removed
text to increase clarity of statements. Additional infor-
mation (e.g., the collection of specimens for genetic test-
ing for targeted treatments) was provided in the speaker
notes to ensure presenters have sufficient information to
answer potential questions posed by community mem-
bers. No changes were suggested relative to the periph-
eral and sociocultural categories.
Reading level assessment
The Flesch Reading Ease test value was 68.2 and the
Flesch-Kincaid Grade Level was 5.5, which met our tar-
get level. In applying linguistic and peripheral strategies,
the language was simplified further. Also, plain language
principles were used by adding images to increase clarity
of the content [44].
Cognitive interview
Results of the community member interviews indicated
only minor modifications in wording were needed for
clarity under the linguistic strategy. For the evidential
strategy, the participants suggested adding a list of risks
in being in a clinical trial, which we added only in the
presenter notes for reference when answering questions,
since they vary across trials. Socioculturally, we added
information on how to participate in a clinical trial if un-
documented, uninsured, and speaks no English.
Community review of new educational module
Overall, participants had positive reviews on the presen-
tation. They perceived it was informative, concise, orga-
nized and timely. The videos that provide the
community member and researcher perspectives and/or
experiences on cancer clinical trials were well-received.
No participants found the material to be culturally in-
sensitive. Members perceived presenters were
knowledgeable on the topic, engaging, prepared, well-
spoken, and effective in responding to the audience
questions and comments. However, some participants
perceived pertinent information was missing on the
topic (e.g., additional information on cancer prevention
and clinical trial phases) or the presentation was lengthy.
See Table 4 for examples of participant feedback. Using
their feedback, pictures were updated (i.e., peripheral
strategy), additional information was added to the
presenters notes on the informed consent process (evi-
dential strategy), and CHEs were identified from all
socio-economical statuses to provide the presentation
(sociocultural strategy).
Final program
Through this formative research process, we developed a
new, 25-slide educational program entitled, “Clinical
Trials: What’s In It For Us?”. The final program
consisted of two presentations designed to be culturally-
appropriate for African Americans and Latinos, plus
video testimonials on cancer clinical trials from commu-
nity members and researchers who were African
American and Latino (in English). There was an
additional Spanish version available for the presentation
and testimonial videos for the Latino community. While
nearly all content was changed from the ENACCT mod-
ule, we added a note acknowledging ENACCT as the
source on relevant slides with any specific content from
the original ENACCT slides.
Discussion
Our goal was to conduct a formative research process to
develop a culturally-appropriate, cancer clinical trial
educational program that improves knowledge, attitudes,
Table 3 Emerging illustrating themes on participants views towards cancer clinical trials and the education program (Continued)
Theme Subthemes Examples of Participant Statements
and she probably didn’t even know about it.” (Mistrust in
Doctors, African American)
”... A lot of times it’s just lack of knowledge. People go through
everyday thinking and they’re not plugged in, or they don’t
have the information to know these things are out there ...
(inaudible), and a lot of people don’t know it’s there.” (Lack of
Information, African American)
Perspectives of Community Health Educators
Definition: Addresses the opinions of the CHEs that delivered








”I felt very comfortable with presenting the slides. I thought
the slides were concise.” (Presenter)
“And they came and did some tweaking, and then we got
back together. So, we had input all along the way.”
(Presenter)
... I’m not sure that people know that there is an opportunity
for them to be a part of this peer education process [Be a
CHE]. Now, if we could find ways to get that out there, just
like getting the word out, that would increase the number of
people involved in the communities that you are trying to pull
into this.” (Presenter)
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willingness, and ultimately participation in cancer clin-
ical trials and biospecimen collection. We intricately in-
terweaved community engagement throughout the
multi-layered, development process to target this pro-
gram, offering a different perspective for the program.
Community involvement through formative research
and message targeting have demonstrated effectiveness
in promoting behavior change [45, 46]. This formative
research process serves as an example on how to apply
CEnR principles and cultural-targeting strategies to de-
velop culturally-appropriate program to increase cancer
clinical trials participation among African Americans
and Latinos.
Past research has applied CEnR principles to develop
clinical trials educational programs, but they were lim-
ited to short-term involvement of community stake-
holders in a consulting role [21–24]. Reflecting Wilkins’
et al. (2018) framework for stakeholder engagement in
health research [47], we used community members of all
levels at varying extents of involvement - team members
(CBO leaders), advisory groups (MVTCP advisory
board), and reviewers/consultants (CHEs, community
members) - to adapt our program for the African
American and Latino communities. This was an
innovative, collaborative method which listened to the
community’s voice and promoted consensus building
throughout the process. We specifically sought input to
make the program relevant, accurate, and culturally ap-
propriate with effective delivery methods. Furthermore,
our CBO leaders served as co-authors to disseminate
our work to academicians.
Previous studies have used formative research to de-
velop culturally-targeted interventions focused on other
topics [48, 49], and the use of community engagement
in formative research has increased over the years [37,
50]. Both approaches have been found effective; how-
ever, as we have noted, few examples exist in the appli-
cation of CEnR principles to culturally target programs
in the formative research process [51]. For example,
Vastine et al. (2005) presented a model to develop a cul-
turally appropriate dietary intervention in a formative
research process using stakeholder participation [51, 52].
Yet, the existing literature provides limited guidance on
how to apply CEnR principles and cultural-targeting
strategies in formative research to ensure a program is
culturally appropriate, with no previous examples identi-
fied on the topic of clinical trials education. We have
demonstrated the incorporation of CEnR during a for-
mative research process to design a culturally target
intervention aimed to increase participation in cancer
clinical trials among Latinos and African Americans.
This formative research and engagement process can be
used to guide the development other programs seeking
to produce behavior change to improve health
outcomes.
Strengths and limitations
A major strength of this process was utilizing our exist-
ing CEnR infrastructure to apply a multi-layered, CEnR
approach and cultural-targeting strategies to develop this
program. We empowered the African American and
Latino communities to advocate for their educational
needs on cancer and the clinical trial process, increasing
their ability to make informed decisions on cancer clin-
ical trial participation. They can also serve as an educa-
tional resource to other community members, increasing
awareness and acceptability of cancer clinical trials, and
possibly clinical trials in general. There are a few limita-
tions. Due to using an iterative, multi-layered approach
for program development, our timeline was extensive to
incorporate community feedback. For example, focus
group feedback led to the development of two presenta-
tions, one for the African American community and one
for the Latino community. However, this timeline could
be shortened if feedback already exists and if only one
presentation is needed. Second, there are logistical bar-
riers that can inhibit clinical trial participation (e.g., lack
of insurance) that the educational program cannot ad-
dress, and thus, could limit the effectiveness of this pro-
gram on clinical trial participation outcomes when
implemented.
Table 4 Feedback and Suggestions from Community Review
Positive Feedback Negative Feedback




• Length is good
• Content brief
• Content informative




• Informed consent process unclear on
ethics slide
• Community member video not
appealing









• Too many slides
• Too much detail
• “Missing information on cancer
prevention”
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Next steps
The next step of our partnership was to implement our
cancer clinical trials educational program in a pilot
study. Our team is evaluating the programs’ impact on
participant knowledge, attitudes, trust, and willingness
related to cancer clinical trials participation, which will
be reported in a future manuscript.
Conclusion
We developed a culturally-appropriate, cancer clinical
trial education program using a multi-layered, iterative
formative research process while applying CEnR princi-
ples and cultural-targeting strategies. It allowed for iden-
tifying logistical barriers and fit the needs of the target
audience, increasing chances of program acceptability
and effectiveness. This program can be adopted by exist-
ing CBOs and institutions to educate these communities
on cancer and clinical trials. This offers the potential to
improve knowledge, attitudes, and behavior related to
cancer clinical trials in the long term.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12889-020-08939-4.
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